Patent details

EP2347261 Title: SELECTION OF COLORECTAL CANCER PATIENTS FOR TREATMENT WITH DRUGS TARGETING EGFR PATHWAY

Basic Information

Publication number:
EP2347261
PCT Application Number:
PCT/US/2009/006267
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097958367
PCT Publication Number:
WO/2010/085234
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SELECTION OF COLORECTAL CANCER PATIENTS FOR TREATMENT WITH DRUGS TARGETING EGFR PATHWAY
French Title of Invention:
SÉLECTION DE PATIENTS SOUFFRANT DE CANCERS COLORECTAUX EN VUE DE TRAITEMENTS PAR DES MÉDICAMENTS CIBLANT LA VOIE EGFR
German Title of Invention:
AUSWAHL VON PATIENTEN MIT KOLOREKTALKARZINOM FÜR EINE BEHANDLUNG MIT AUF DEN EGFR-WEG ZIELENDEN ARZNEISTOFFEN
SPC Number:

Dates

Filing date:
20/11/2009
Grant date:
15/08/2012
EP Publication Date:
15/08/2012
PCT Publication Date:
29/07/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/07/2011
EP B1 Publication Date:
15/08/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/11/2012
Expiration date:
20/11/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/11/2009
 
 

Name:
Biodesix Inc.
Address:
2790 Wilderness Place, Suite 100, Boulder, CO 80301, United States (US)

Inventor

1

Name:
GRIGORIEVA Julia
Address:
United States (US)

2

Name:
TSYPIN Maxim
Address:
United States (US)

3

Name:
RÖDER Heinrich
Address:
United States (US)

Priority

Priority Number:
321394
Priority Date:
20/01/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
G01N 33/574;
Filing date Document type Number of pages